Epoxidase-2 selective inhibitor as well as preparation method and application thereof

A cyclooxygenase and selective technology, applied in the field of medicine, can solve the problems of inappropriate COX-2/COX-1 selectivity, side effects, and limited COX-2 inhibitors, and achieve cheap and easy-to-obtain raw materials and synthetic routes Effects of Short, Significant Selective Inhibition

Inactive Publication Date: 2015-06-10
GUANGZHOU YINGYU PHARMA TECH CO LTD
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the problem in this field is that the selectivity for COX-2 / COX-1 is not suitable. No selectivity and too high selectivity will cause certain side effects. COX-2 inhibitors with moderate selectivity will have good Clinical use effect, the COX-2 inhibitors currently available for clinical selection are still very limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Epoxidase-2 selective inhibitor as well as preparation method and application thereof
  • Epoxidase-2 selective inhibitor as well as preparation method and application thereof
  • Epoxidase-2 selective inhibitor as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 (compound 1)

[0035] The preparation method of 4-[3,5-bis(2-hydroxyphenyl)-1-(1,2,4-triazolyl)]benzenesulfonamide, the steps comprising:

[0036] (1) Add 40ml of xylene and salicylic acid (17.3g, 120mmol) into a 250ml reaction bottle, slowly add 10ml of thionyl chloride with a dropping funnel, leave it for 30min after the dropwise addition, add salicylamide (11.2g, 80mmol), stirred and reacted at room temperature (20-25°C) for 5h, tracked the reaction by TLC, after the reaction was complete, evaporated the organic solvent under reduced pressure to obtain a yellow viscous solid, added 50ml of ethanol, heated to reflux for 1h, and cooled to room temperature , stood still, and 7.6g of yellow powdery solid compound 1a was precipitated.

[0037] (2) Add compound 1a (0.72g, 3mmol) and p-hydrazinobenzenesulfonamide (0.67g, 3.5mmol) to 25ml of methanol, heat to reflux for 10h, follow the reaction by thin-layer chromatography, and cool to room temperature after the r...

Embodiment 2

[0039] Example 2 (compound 1)

[0040] The preparation method of 4-[3,5-bis(2-hydroxyphenyl)-1-(1,2,4-triazolyl)]benzenesulfonamide, the steps comprising:

[0041] (1) Add salicylamide (11.2g, 80mmol) and 40ml of xylene into a 250ml reaction bottle, heat to dissolve, slowly drop salicyloyl chloride (22.7g, 0.12mol) into the reaction solution, after adding , stirred at room temperature for 5 hours, followed by thin-layer chromatography. After the reaction was complete, the organic solvent was evaporated under reduced pressure to obtain a yellow viscous solid, which was added with 25ml of ethanol, refluxed for 1 hour, cooled to room temperature, left to stand, and yellow needle-shaped crystals were precipitated , the mother liquor was further concentrated and crystallized, and a total of 7.8 g of compound 1a was obtained.

[0042] (2) Add compound 1a (0.72g, 3mmol) and p-hydrazinobenzenesulfonamide (0.67g, 3.5mmol) to 25ml of methanol, heat to reflux for 10h, follow the reactio...

Embodiment 3

[0044] Example 3 (compound 1)

[0045] The preparation method of 4-[3,5-bis(2-hydroxyphenyl)-1-(1,2,4-triazolyl)]benzenesulfonamide, the steps comprising:

[0046] (1) Add 40ml of xylene and salicylic acid (17.3g, 120mmol) into a 250ml reaction bottle, slowly add 10ml of thionyl chloride with a dropping funnel, leave it for 30min after the dropwise addition, add salicylamide (11.2g, 80mmol), reacted at room temperature for 5h, tracked the reaction by thin-layer chromatography, after the reaction was complete, evaporated the organic solvent under reduced pressure to obtain a yellow viscous solid, added 50ml of ethanol, heated to reflux for 1h, cooled to room temperature, stood still, and precipitated 7.6g Yellow powdery solid compound 1a.

[0047] (2) Add compound 1a (0.76g, 3mmol), p-hydrazinobenzenesulfonamide hydrochloride (0.65g, 3.5mmol) into 25ml of methanol, reflux for 12h, cool to room temperature, and then continue to drop to 0-5 ℃ for 1h. The precipitated solid was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an epoxidase-2 selective inhibitor as well as a preparation method and application thereof. According to the epoxidase-2 selective inhibitor, with substituted benzamide and a substituted benzoic acid derivative as raw materials, a 4-[3,5-bis(substituted-phenyl)-1-(1,2,4-triazole)] benzenesulfonic acid derivative is obtained through condensation reaction and ring closing reaction of a p-hydrazino-benzenesulfonic acid derivative. The epoxidase-2 selective inhibitor has the beneficial effects that the epoxidase-2 selective inhibitor has a significant selective inhibiting effect on epoxidase COX-2 activity, and is capable of obviously inhibiting foot swelling in mice caused by carrageenin; and a target compound is expected to become a medicine for treating inflammation, rheumatoid arthritis, and diseases related to epoxidase-2.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a cyclooxygenase-2 (cyclooxygenase-2 (COX-2)) selective inhibitor and its preparation method and application. Background technique [0002] Cyclooxygenase (COX) is a key enzyme that controls the metabolism of arachnidonic acid (AA) and the biosynthesis of prostaglandin (arachidonic acid, PG). There are two isoenzymes of cyclooxygenase, cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), and the regulation of the two isoenzymes at the structure and molecular level is different. features. COX-1 exists in a variety of tissues, most of which are stomach, kidney, and platelets. The PG produced by it can protect the normal physiological functions of the organ and is a physiologically active component; COX-2 is induced by inflammatory factors and produced in the inflammatory site PG produced by macrophages, synoviocytes, chondrocytes, endothelial cells, fibroblasts and other cells can cause...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D249/08A61P29/00A61P19/02A61P43/00
CPCC07D249/08
Inventor 康健
Owner GUANGZHOU YINGYU PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap